Analyst Research Report Snapshot


Johnson & Johnson




MarketLine (a Datamonitor Company)


08 Jan 2014





Companies referenced:


Available for Immediate Download

Johnson & Johnson - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Johnson & Johnson required for business and competitor intelligence needs - A study of the major internal and external factors affecting Johnson & Johnson in the form of a SWOT analysis - An in-depth view of the business model of Johnson & Johnson including a breakdown and examination of key business segments - Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Johnson & Johnson - Intelligence on Johnson & Johnsonnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Johnson & Johnson, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Johnson & Johnson (J&J or 'the company') is the world's leading provider of diverse health products. It is engaged in the research, development, manufacture and sale of consumer health care products, pharmaceuticals, medical devices and diagnostics. The company has more than 275 operating companies. It operates in the Americas, Europe, Asia Pacific and Africa. The company is headquartered in New Brunswick, New Jersey, and employed about 127,600 people as of December 30, 2012. The company recorded revenues of $67,224 million during the financial year ended December 2012 (FY2012), an increase of 3.4% over FY2011. The operating profit of the company was $13,243.1 million* in FY2012, a decrease of 19.8% over FY2011. The net profit was $10,853 million in FY2012, an increase of 12.2% over FY2011. *Earnings before interest and taxes. Reasons to Purchase: - Gain understanding of Johnson & Johnson and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Johnson & Johnson as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Johnson & Johnson’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.